Cargando…

Stem Cells for Huntington’s Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington’s Disease

Huntington’s disease (HD) research is entering an exciting phase, with new approaches such as huntingtin lowering strategies and cell therapies on the horizon. Technological advances to direct the differentiation of stem cells to desired neural types have opened new strategies for restoring damaged...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293637/ https://www.ncbi.nlm.nih.gov/pubmed/33814456 http://dx.doi.org/10.3233/JHD-210473

Ejemplares similares

The cytoprotective role of GM1 ganglioside in Huntington disease cells
por: Hart, Hannah S., et al.
Publicado: (2022)

Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset
por: Harris, Kate L., et al.
Publicado: (2022)

Refining the diagnosis of Huntington disease: the PREDICT-HD study
por: Biglan, Kevin M., et al.
Publicado: (2013)

Molecule of the month: miRNA and Huntington's disease (HD)
por: Shapshak, Paul
Publicado: (2013)

Disease Burden of Huntington’s Disease (HD) on People Living with HD and Care Partners in Canada
por: Shaw, Eileen, et al.
Publicado: (2022)

The societal cost of Huntington's disease: are we underestimating the burden?
por: Jones, C., et al.
Publicado: (2016)

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
por: Frank, Samuel
Publicado: (2009)

Developing stem cell therapies for juvenile and adult-onset Huntington’s disease
por: Fink, Kyle D, et al.
Publicado: (2015)

Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis
por: Liang, Xue-Song, et al.
Publicado: (2023)

Cognitive processes of apathy in Huntington’s disease show high sensitivity to disease progression
por: Hare, Emily, et al.
Publicado: (2022)

Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease
por: Choompoo, Narawadee, et al.
Publicado: (2021)

Detection of Huntington’s disease decades before diagnosis: the Predict-HD study
por: Paulsen, J S, et al.
Publicado: (2008)

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
por: Klöppel, Stefan, et al.
Publicado: (2015)

Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?
por: Tucci, Paolo, et al.
Publicado: (2022)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Prevalence of neurocognitive disorder in Huntington’s disease using the Enroll-HD dataset
por: Sierra, Luis A., et al.
Publicado: (2023)

Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington’s Disease
por: Osmand, Alexander P., et al.
Publicado: (2016)

Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease
por: Crane, Andrew T., et al.
Publicado: (2014)

Combination of stem cell and gene therapy ameliorates symptoms in Huntington’s disease mice
por: Cho, In Ki, et al.
Publicado: (2019)

Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT‐HD
por: Long, Jeffrey D., et al.
Publicado: (2015)

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
por: Reed, Eric R., et al.
Publicado: (2018)

Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease
por: Norrbacka, Susanna, et al.
Publicado: (2019)

Enriched Environment and Exercise Enhance Stem Cell Therapy for Stroke, Parkinson’s Disease, and Huntington’s Disease
por: Berlet, Reed, et al.
Publicado: (2022)

Monkey hybrid stem cells develop cellular features of Huntington's disease
por: Laowtammathron, Chuti, et al.
Publicado: (2010)

Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
por: Tousley, Adelaide, et al.
Publicado: (2016)

Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington’s disease
por: Saha, Sudeepto, et al.
Publicado: (2022)

Resurrection of sildenafil: potential for Huntington’s Disease, too?
por: Achenbach, Jannis, et al.
Publicado: (2022)

Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells
por: Wiatr, Kalina, et al.
Publicado: (2017)

Intracerebral Transplantation of BDNF-overexpressing Human Neural Stem Cells (HB1.F3.BDNF) Promotes Migration, Differentiation and Functional Recovery in a Rodent Model of Huntington's Disease
por: Kim, Hyun Sook, et al.
Publicado: (2020)

Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?
por: Precious, Sophie V., et al.
Publicado: (2017)

Facilitating Huntington's disease research: plasma neurofilament levels as a promising enrichment biomarker for HD-ISS stage 1
por: Sampaio, Cristina, et al.
Publicado: (2023)

Volumetric Analysis of the Hypothalamus in Huntington Disease Using 3T MRI: The IMAGE-HD Study
por: Gabery, Sanaz, et al.
Publicado: (2015)

Accuracy of automated amygdala MRI segmentation approaches in Huntington's disease in the IMAGE‐HD cohort
por: Alexander, Bonnie, et al.
Publicado: (2020)

Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
por: Sathe, Swati, et al.
Publicado: (2021)

Autonomic Changes in Juvenile-Onset Huntington’s Disease
por: Schultz, Jordan L., et al.
Publicado: (2020)

In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington’s Disease
por: Jeon, Iksoo, et al.
Publicado: (2014)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study
por: Langbehn, Douglas R., et al.
Publicado: (2023)

Cell-based technologies for Huntington’s disease
por: Haddad, Mônica Santoro, et al.
Publicado: (2016)

Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease
por: Olson, Scott D., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nfi5no1cr2jih95teebn4h55kq